To further substantiate our ex vivo findings, we examined the cellular expression/localization levels of SOX2, PI3KR1, OCT3/4, N-Cadherin, E-Cadherin, Nanog, LIF, and CD44 in residual PC. The gene discussed is SOX2; the disease is pachyonychia congenita.